Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines showed strong immune responses in ...

US biotech Novavax (Nasdaq: NVAX) has reported that its experimental combination COVID-19 and influenza vaccine generated ...

Amidst an ongoing outbreak of a deadly bird flu virus in livestock, the US Department of Agriculture is doing more to prevent ...

Novavax (NVAX) stock gains as the company reports promising Phase 3 trial results for its COVID-19-Influenza combo vaccine and stand-alone flu shot. Read more here.

Novavax NVAX announced encouraging results from an initial cohort of a late-stage study evaluating its experimental ...

The Gaithersburg, Md., biotechnology company said Wednesday that results of the initial cohort of vaccines showed both the Covid-19-influenza combination and flu-vaccine candidates induced immune ...

The Department of Health and Human Services has defended cuts to vaccine research with statements that mislead on the safety ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include individuals 18-59 years of age who are at increased risk for severe illness from ...

USA-based biotech Vaxart has reported positive top-line results from a Phase I trial comparing its second-generation oral ...

Moderna's combo shot for flu and COVID-19 showed strong antibody responses The U.S. Food and Drug Administration wants more proof that it protects against sickness and not just antibodies Modern ...